Serum free and total prostate-specific antigen levels in patients with liver disease-Reference-Cited by-同舟云学术

Serum free and total prostate-specific antigen levels in patients with liver disease

Published:1998-11 Issue:5 Volume:52 Page:825-827
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Kiliç Sahi̇r,Günteki̇n Erol,Danişman Ahmet,Kukul Erdal,Süleymanlar İnci̇,Sevük Meti̇n

Publisher

Elsevier BV

Subject

Urology

Reference18 articles.

1. Purification of human prostate-specific antigen;Wang;Invest Urol,1979

2. Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors;Christensson;Eur J Biochem,1990

3. Prostate-specific antigen in serum occurs predominantly in complex with α1-antichymotrypsin;Lilja;Clin Chem,1991

4. A complex between prostate-specific antigen and α1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostate cancer;Stenman;Cancer Res,1991

5. Serum prostate-specific antigen complexed to α1-antichymotrypsin as an indicator of prostate cancer;Christensson;J Urol,1993

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between serum prostate-specific antigen level and diabetes, obesity, hypertension, and the laboratory parameters related to glucose tolerance, hepatic function, and lipid profile: implications for modification of prostate-specific antigen threshold;International Journal of Clinical Oncology;2019-08-22

2. Is Serum Prostate-Specific Antigen a Reliable Prostate Cancer Marker in Liver Transplant Candidates;Experimental and Clinical Transplantation;2019-08

3. Association between Liver Fibrosis and Serum PSA among U.S. Men: National Health and Nutrition Examination Survey (NHANES), 2001–2010;Cancer Epidemiology Biomarkers & Prevention;2019-06-03

4. Infectious mononucleosis, other infections and prostate-specific antigen concentration as a marker of prostate involvement during infection;International Journal of Cancer;2016-01-21

5. The likelihood of having a serum PSA level of ≥2.5 ng/mL according to the degree of fatty liver disease in a screened population;Canadian Urological Association Journal;2015-12-14